Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia

Citation
Kp. Figueroa et al., Association of moderate polyglutamine tract expansions in the slow calcium-activated potassium channel type 3 with ataxia, ARCH NEUROL, 58(10), 2001, pp. 1649-1653
Citations number
34
Categorie Soggetti
Neurology,"Neurosciences & Behavoir
Journal title
ARCHIVES OF NEUROLOGY
ISSN journal
00039942 → ACNP
Volume
58
Issue
10
Year of publication
2001
Pages
1649 - 1653
Database
ISI
SICI code
0003-9942(200110)58:10<1649:AOMPTE>2.0.ZU;2-R
Abstract
Background: The small-conductance calcium-activated potassium channel gene (hSKCa3) contains 2 CAG repeats, 1 of which is highly polymorphic. Although this repeat is not pathologically expanded in patients with schizophrenia, some studies have suggested an allelic association with schizophrenia. CAG expansions in other genes such as the alpha1 subunit of a brain-specific P /Q-type calcium channel gene cause spinocerebellar ataxia type 6, whereas t he length of the CAG repeat in the RAI1 gene modifies the age of onset of s pinocerebellar ataxia type 2. Objectives: To evaluate expansions in the hSKCa3 polyglutamine domain as ca usative for ataxia, and to study the association between the length of the polyglutamine repeat and the presence of ataxia. Methods: We analyzed this repeat in 122 patients with autosomal dominant ce rebellar ataxia, or sporadic ataxia, and compared allele distribution with 750 alleles seen in 2 healthy control groups and 172 alleles in patients wi th Parkinson disease. Results: The distribution of alleles in ataxia patients and controls was si gnificantly different by Wilcoxon rank test (P < .001). Twenty-two or more polyglutamine tracts were more common in ataxia patients compared with cont rols by chi (2) analysis (P < .001). Conclusion: Longer stretches of polyglutamines in a human potassium channel are not causative for ataxia, but they are associated with the presence of ataxia. There is no association with the presence of Parkinson disease.